Previous Page  813 / 827 Next Page
Information
Show Menu
Previous Page 813 / 827 Next Page
Page Background

843

Stimulation of camel polyclonal antibody against human T cell

immunoglobulin and Mucin-3

Homayouni,V.

Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

Background:

T cell Immunoglobulin and Mucin (TIM)-3 is a type I

transmembrane glycoprotein and amember of theTIM family which

is identified as a receptor. This receptor expresses on T helper type 1

(Th1) cells and binds to galectin-9 (Gal9). This interaction induces an

inhibitory signal, resulting inapoptosisofTh1cells andcytotoxicCD8

T cells in vitro. Antibody therapy for immune checkpoint blockade

has achieved promising results for several types of malignant

tumors. Therefore, this immunomodulatory molecule may be used

as a novel target for clinical purposes.The productionof camel heavy

chain antibodies (HCAbs) against TIM-3-expressing cell line was

reported in this study.

Methods:

A pre-synthesized human TIM-3cDNA was insertd into

pcDNA3.1 plasmid and the new construct was transfected in HEK

cell. TIM-3 expressionwas confirmed by qRT-PCR and flowcytometry

methods. A 6 months old camel was immunized with the lysate

prepared from rTIM-3 expressing HEK cells 4times.Then, the anti-

TIM-3 antibody level was evaluated using ELISA method.

Results and conclusion:

TIM-3 was successfully cloned in HEK cells

and more than 88% of the cells expressed TIM-3. Hence, using HEK

cells was produced a readily obtainable source of TIM-3. It was used

for camel immunization. High level of anti-TIM-3 antibody was

detected in its serum after the final injection. This antibody may be

useful for future diagnostic or therapeutic approaches.

B cell depletion compromises CD8+ T cell response in murine

T

cruzi

infection

FioccaVernengo,F.,Beccaria,C.G.,AraujoFurlán,C.,ToselloBoari,J.,

GorositoSerrán,M.,Montes,C.,AcostaRodriguez, E.V., Gruppi,A.

SchoolofChemistry.NationalUniversityofCórdoba,Córdoba,

Argentina

Considering CD8+T cells play a major role in

T. cruzi

protective

immunity, the signals that promote the generation and

maintenance of CD8+T cell responses needs to be identified. Many

reports highlight the role of B cells in promoting cellular immunity;

however, if B cells affect CD8 responses remain uncharacterized.

To assess B-cell function in promoting CD8 responses in Chagas

disease, C57BL/6 mice were intraperitoneally injected with anti-

CD20, to deplete B cells, or with control antibodies. Eight days after

treatment, mice were infected with 5000 trypomastigotes. Flow

cytometric analysis using tetramer staining revealed that at day 14

post infection, depleted mice had a lower frequency of parasite-

specific CD8+T cells in spleen, blood and liver compared to control

mice (p=0,0003, 0,0353 and 0,0447 respectively). Interestingly, B-cell

deficient mice showed higher percentages of naïve CD8+T cells

(CD44-CD62L+)andlowerfrequencyofeffectormemoryCD8+Tcells

(CD44+CD62L-). CD8+T cells from B-cell depleted mice presented

a Memory Precursor Effectors Cells phenotype unlike CD8+T cells

from B-cell sufficient mice who exhibit a Short Lived Effectors

Cells phenotype. Also, we found that depleted mice had lower

frequencies of IFN-γ- or TNF-producing CD8+T cells and displayed

lower apoptosis and proliferation rate. Unexpectedly CD8+T cells

from B-cell depleted mice overexpressed molecules associated

to activation/migration than control mice. These results identify

functional defects in CD8+T cells generated in B cell-depleted mice,

highlighting B cell influence on CD8+T cell response. Furthermore,

our study urges caution during B-cell depletion therapies due to its

possible side effects on the immunity against infections.

Transgenic expression of N-acetylglucosaminyltransferase V

in T cells accelerates autoimmune diabetes in NOD mice by

enhancing pathogenicity of CD8 T cells

Chien,M.-W.

1

,Khoo,K.-H.

2

,Sytwu,H.-K.

1

1

National Defense Medical Center, Department and Graduate

Institute of Microbiology and Immunology, Taipei, Taiwan, Republic

of China,

2

Academia Sinica, Institute of Biological Chemistry, Taipei,

Taiwan, Republic of China

β1,6

N-acetylglucosaminyltransferase

V

(Mgat5)

is

a

glycosyltransferasethatincreasesN-glycanbranchingbytransferring

N- acetylglucosamine (GlcNAc) fromUDP-GlcNAc to hydroxyl group

on carbon 6 of the α1,6-linked mannose of N-glycans. Previous

studies have shown that deficiency of Mgat5 in mice decreased

the T cell activation thresholds and exacerbated the incidence of

experimental autoimmune encephalomyelitis (EAE). The non-obese

diabetic (NOD) mice, a widely used animal model for human type 1

diabetes (T1D), developed spontaneous autoimmune diabetes and

mainly caused byT cell-dependent destruction of pancreatic β-cells.

Recently,NODmouseisreportedasanEAEsusceptiblestrainsinceless

N-glycan branching expressed on T cells. However, the relationship

between Mgat5-mediated N-glycan branching and diabetogenic

processingonT cells inNOD mice is still unknown. Here, weobserved

that Mgat5 transgenic T cells expressed higher level of N-glycan

branching and had attenuated proliferation potential compared to

control littermate T cells in NOD mice. Unexpectedly, a significantly

higher diabetic incidence was found in both Mgat5 transgenic

NOD mice and Mgat5/NY8.3 doubly transgenic mice that express a

highly pathogenic transgenic TCR on CD8 T cells. Further, the higher

diabetic incidence was also found in NOD/SCID recipients received

adoptive transfer of Mgat5-overexpressed CD8 T cells, indicating

that Mgat5 overexpression enhances the pathogenic properties of

CD8T cells in an antigen-specificmanner. Taken together, our results

suggest that upregulated Mgat5-mediated N- glycan branching on

CD8T cells contributes to autoimmune diabetes inNODmice.

Features of phenotypic structure and functional activity of

cord blood immune cells depending a gestational age

Lyapunov,V.

1

,Chistyakova,G.

1

,Bychkova,S.

2

,Remizova,I.

1

,Chereshnev,

V.

3

,Ustyantseva,L.

2

1

MotherandChildCareResearhInstituteinRussianPublicHealth

Ministry,ImmunologyandClinicalMicrobiology,Ekaterinburg,

RussianFederation,

2

MotherandChildCareResearhInstituteinRussian

PublicHealthMinistry,PathologyofPrematureInfants, Ekaterinburg,

RussianFederation,

3

InstituteofImmunologyandPhysiologyUBRAS,

Ekaterinburg,RussianFederation

In order to identify genotypic characteristics of the composition and

functional activity of immune cells of umbilical cord blood (UCB) as a

function of gestational age (GA), studied 102 UCB samples of babies

born at 25-28, 29-32 and 33-36 weeks of GA and 31 UCB samples

from comparison group (37-41 weeks GA). By the method of flow